Genprex Inc (GB:0A8I)

Genprex (0A8I) Stock Price & Analysis


0A8I Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.76 - $2.62
Previous Close$0.88
Average Volume (3M)2.62K
Market Cap
Enterprise Value$28.18M
Total Cash (Recent Filing)$18.08M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)N/A
Aug 13, 2019
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares OutstandingN/A
10 Day Avg. Volume1,203
30 Day Avg. Volume2,624
Standard DeviationN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.18
Enterprise Value/Ebitda-3.19
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0




What was Genprex Inc’s price range in the past 12 months?
Genprex Inc lowest stock price was $0.76 and its highest was $2.62 in the past 12 months.
    What is Genprex Inc’s market cap?
    Currently, no data Available
    When is Genprex Inc’s upcoming earnings report date?
    Genprex Inc’s upcoming earnings report date is Aug 13, 2019 which is 1385 days ago.
      How were Genprex Inc’s earnings last quarter?
      Genprex Inc released its earnings results on May 15, 2019. The company reported -$0.141 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.141.
        Is Genprex Inc overvalued?
        According to Wall Street analysts Genprex Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Genprex Inc pay dividends?
          Genprex Inc does not currently pay dividends.
          What is Genprex Inc’s EPS estimate?
          Genprex Inc’s EPS estimate is -$0.21.
            How many shares outstanding does Genprex Inc have?
            Currently, no data Available
            What happened to Genprex Inc’s price movement after its last earnings report?
            Genprex Inc reported an EPS of -$0.141 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Genprex Inc?
              Currently, no hedge funds are holding shares in GB:0A8I


              Genprex Stock Smart Score

              The Genprex Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Genprex Inc

              Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.


              Forecast EPS vs Actual EPS

              Similar Stocks
              Price & Change
              Cardiff Oncology
              Passage Bio
              Abeona Therapeutics
              Assembly Biosciences

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis